Due to its potent effects on reducing meal size and body weight in both rodent and human studies [4,21,22,23], oxytocin is currently under clinical investigation as a therapeutic for obesity treatment [24,25,26,27,28,29,30,31]. Here, OXT is linked to obesity due to melanocortin 4 receptor deficiency.